NDC 70518-2007

Ritonavir

Ritonavir

Ritonavir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Ritonavir.

Product ID70518-2007_86410121-d579-8ebf-e053-2a91aa0ab05f
NDC70518-2007
Product TypeHuman Prescription Drug
Proprietary NameRitonavir
Generic NameRitonavir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2019-04-09
Marketing CategoryANDA / ANDA
Application NumberANDA206614
Labeler NameREMEDYREPACK INC.
Substance NameRITONAVIR
Active Ingredient Strength100 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 70518-2007-0

30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2007-0)
Marketing Start Date2019-04-09
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70518-2007-0 [70518200700]

Ritonavir TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206614
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-04-09

Drug Details

Active Ingredients

IngredientStrength
RITONAVIR100 mg/1

OpenFDA Data

SPL SET ID:768df83f-822d-468a-81dc-0426e2e8d13f
Manufacturer
UNII

Pharmacological Class

  • HIV Protease Inhibitors [MoA]
  • Cytochrome P450 3A Inhibitor [EPC]
  • Protease Inhibitor [EPC]
  • Cytochrome P450 3A Inhibitors [MoA]
  • Cytochrome P450 2D6 Inhibitors [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]
  • Cytochrome P450 3A Inducers [MoA]
  • P-Glycoprotein Inhibitors [MoA]
  • Breast Cancer Resistance Protein Inhibitors [MoA]
  • Cytochrome P450 3A4 Inhibitors [MoA]
  • Cytochrome P450 1A2 Inducers [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • UDP Glucuronosyltransferases Inducers [MoA]

NDC Crossover Matching brand name "Ritonavir" or generic name "Ritonavir"

NDCBrand NameGeneric Name
0054-0407RitonavirRitonavir
31722-597RitonavirRitonavir
60687-364RitonavirRitonavir
60687-420RitonavirRitonavir
65162-061RitonavirRitonavir
65862-687RitonavirRitonavir
68382-696RitonavirRitonavir
70518-1086RitonavirRitonavir
70518-1519RitonavirRitonavir
70518-2007RitonavirRitonavir
0074-1940NorvirRitonavir
0074-2340NorvirRitonavir
0074-3333NorvirRitonavir
0074-3399NorvirRitonavir
50090-1162NorvirRitonavir
53808-1119NorvirRitonavir

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.